Takeda launches mobile app XPERT EASE to help treatment of genetic disorders
The XPERT EASE application is designed to keep in mind such challenges while managing lysosomal storage disorders, the drug firm said.
New Delhi: Drug firm Takeda India on Friday said it has launched a mobile application for the exclusive use of healthcare professionals to address the digital ecosystem for the management of patients with genetic diseases.
The application would enable an efficient digital ecosystem for disease updates and dose calculation for improved management of patients with rare lysosomal storage disorders, Takeda India said in a statement.
Screening, diagnosis, and treatment of genetic diseases have often been identified as challenging, including advising the dosage of medicines specific to patients'' individual needs.
The XPERT EASE application is designed to keep in mind such challenges while managing lysosomal storage disorders, the drug firm said.
Read also: Takeda India named Top Employer in 2021
''At Takeda, we are keen to enable faster diagnosis and access of patients to our medicines and innovative therapies. The XPERT EASE application enables healthcare professionals to raise suspicion index, leading to early diagnosis and better disease management," Takeda India Medical Affairs Head Sandeep Arora said.
Healthcare professionals can access the applications through the Apple App Store and Google Play Store, the company said.
